Jimmy Charbel Haouilou, MD | |
29519 Harper Ave, Saint Clair Shores, MI 48081 | |
(586) 270-5100 | |
(586) 270-5111 |
Full Name | Jimmy Charbel Haouilou |
---|---|
Gender | Male |
Speciality | Vascular Surgery |
Experience | 21 Years |
Location | 29519 Harper Ave, Saint Clair Shores, Michigan |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063676286 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 4301084691 (Michigan) | Secondary |
2086S0129X | Surgery - Vascular Surgery | 4301084691 (Michigan) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Affinity Home Care | Saint clair shores, MI | Home health agency |
Reverence Home Health And Hospice | Clinton township, MI | Home health agency |
Ascension St John Hospital | Detroit, MI | Hospital |
Beaumont Hospital - Grosse Pointe | Grosse pointe, MI | Hospital |
Ascension Macomb Oakland Hosp-warren Campus | Warren, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Premier Vascular Associates Pllc | 0042430548 | 2 |
News Archive
A set of emerging diagnostic tools may help identify breast cancer patients who are most likely to benefit from therapies that target important enzymes fueling a range of subtypes, including BCRA-mutated and triple negative cancers.
Ortho-McNeil-Janssen Pharmaceuticals Inc., a unit of Johnson & Johnson, recalled about 16,000 bottles of its Risperdal schizophrenia drug on reports of an uncharacteristic odor. The recall affects one lot that was shipped between Aug. 27, 2010, and Feb. 15, 2011.
Haemacure Corporation announces that it has obtained authorization from the Superior Court of the Province of Québec to sell its assets to Angiotech Pharmaceuticals, Inc., a secured creditor of Haemacure. The United States Bankruptcy Court previously authorized the sale to Angiotech of the assets of Haemacure's U.S. subsidiary.
Cohera Medical, Inc., a rapidly growing medical device company, announced today that it has received CE Mark approval for its lead product, TissuGlu® Surgical Adhesive. CE Mark approval allows TissuGlu to be sold in the European Union.
› Verified 4 days ago
Entity Name | Premier Vascular Associates Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972904951 PECOS PAC ID: 0042430548 Enrollment ID: O20141006000508 |
News Archive
A set of emerging diagnostic tools may help identify breast cancer patients who are most likely to benefit from therapies that target important enzymes fueling a range of subtypes, including BCRA-mutated and triple negative cancers.
Ortho-McNeil-Janssen Pharmaceuticals Inc., a unit of Johnson & Johnson, recalled about 16,000 bottles of its Risperdal schizophrenia drug on reports of an uncharacteristic odor. The recall affects one lot that was shipped between Aug. 27, 2010, and Feb. 15, 2011.
Haemacure Corporation announces that it has obtained authorization from the Superior Court of the Province of Québec to sell its assets to Angiotech Pharmaceuticals, Inc., a secured creditor of Haemacure. The United States Bankruptcy Court previously authorized the sale to Angiotech of the assets of Haemacure's U.S. subsidiary.
Cohera Medical, Inc., a rapidly growing medical device company, announced today that it has received CE Mark approval for its lead product, TissuGlu® Surgical Adhesive. CE Mark approval allows TissuGlu to be sold in the European Union.
› Verified 4 days ago
Entity Name | Beaumont Medical Group- Specialty Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1578072906 PECOS PAC ID: 7214299866 Enrollment ID: O20180320002549 |
News Archive
A set of emerging diagnostic tools may help identify breast cancer patients who are most likely to benefit from therapies that target important enzymes fueling a range of subtypes, including BCRA-mutated and triple negative cancers.
Ortho-McNeil-Janssen Pharmaceuticals Inc., a unit of Johnson & Johnson, recalled about 16,000 bottles of its Risperdal schizophrenia drug on reports of an uncharacteristic odor. The recall affects one lot that was shipped between Aug. 27, 2010, and Feb. 15, 2011.
Haemacure Corporation announces that it has obtained authorization from the Superior Court of the Province of Québec to sell its assets to Angiotech Pharmaceuticals, Inc., a secured creditor of Haemacure. The United States Bankruptcy Court previously authorized the sale to Angiotech of the assets of Haemacure's U.S. subsidiary.
Cohera Medical, Inc., a rapidly growing medical device company, announced today that it has received CE Mark approval for its lead product, TissuGlu® Surgical Adhesive. CE Mark approval allows TissuGlu to be sold in the European Union.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Jimmy Charbel Haouilou, MD 29519 Harper Ave, Saint Clair Shores, MI 48081-1275 Ph: (586) 270-5100 | Jimmy Charbel Haouilou, MD 29519 Harper Ave, Saint Clair Shores, MI 48081 Ph: (586) 270-5100 |
News Archive
A set of emerging diagnostic tools may help identify breast cancer patients who are most likely to benefit from therapies that target important enzymes fueling a range of subtypes, including BCRA-mutated and triple negative cancers.
Ortho-McNeil-Janssen Pharmaceuticals Inc., a unit of Johnson & Johnson, recalled about 16,000 bottles of its Risperdal schizophrenia drug on reports of an uncharacteristic odor. The recall affects one lot that was shipped between Aug. 27, 2010, and Feb. 15, 2011.
Haemacure Corporation announces that it has obtained authorization from the Superior Court of the Province of Québec to sell its assets to Angiotech Pharmaceuticals, Inc., a secured creditor of Haemacure. The United States Bankruptcy Court previously authorized the sale to Angiotech of the assets of Haemacure's U.S. subsidiary.
Cohera Medical, Inc., a rapidly growing medical device company, announced today that it has received CE Mark approval for its lead product, TissuGlu® Surgical Adhesive. CE Mark approval allows TissuGlu to be sold in the European Union.
› Verified 4 days ago
Dr. Nagalingappa Bhadra Chari, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 29900 Harper Ave, Saint Clair Shores, MI 48082 Phone: 586-294-4440 | |
Steven R Hendrick, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 25631 Little Mack Ave Lowr Level, Saint Clair Shores, MI 48081 Phone: 586-443-2998 Fax: 586-443-2309 | |
Karen L. Summe, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 29000 Little Mack Ave Ste B, Saint Clair Shores, MI 48081 Phone: 586-774-8811 Fax: 586-774-6773 | |
Dr. Mohammed Sahly, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 29000 Little Mack Ave, Saint Clair Shores, MI 48081 Phone: 586-774-8811 | |
Dr. Arpit Aggarwal, DO Surgery Medicare: Medicare Enrolled Practice Location: 29519 Harper Ave, Saint Clair Shores, MI 48081 Phone: 586-343-8717 Fax: 877-255-4705 | |
Abdelkader Hawasli, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 24911 Little Mack Ave, Ste B, Saint Clair Shores, MI 48080 Phone: 586-774-8811 Fax: 586-774-6773 |